|
Table 112-3. American Joint Committee on Cancer (AJCC)/Union Internationale Contre le Cancer (UICC) 1997 Staging System for Male and Female Carcinoma of the Urethra |
|
Tumor (T) |
|
|
Tx |
Tumor cannot be assessed |
|
T0 |
No evidence of primary tumor |
|
Tis |
Carcinoma in situ |
|
Ta |
Noninvasive papillary, polypoid, or verrucous carcinoma |
|
T1 |
Invades subepithelial connective tissue |
|
T2 |
Invades any of the following: prostatic stroma, corpus spongiosum, or periurethral musculature |
|
T3 |
Invades any of the following: corpus cavernosum, beyond prostatic capsule, anterior vagina, or bladder neck (extraprostatic extension) |
|
T4 |
Invades other adjacent organs (Transitional cell carcinoma of the prostate [prostatic urethra]) |
|
Tis pu |
Carcinoma in situ, involvement of prostatic urethra |
|
Tis pd |
Carcinoma in situ, involvement of prostatic ducts |
|
T1 |
Invades subepithelial connective tissue |
|
T2 |
Invades prostatic stroma, corpus spongiosum, or periurethral musculature |
|
T3 |
Invades corpus cavernosum, beyond prostatic extension) |
|
T4 |
Invades other adjacent organs (invasion of bladder) |
|
Nodes (N) |
|
|
Nx |
Regional lymph nodes cannot be assessed |
|
N0 |
No regional lymph node metastasis |
|
N1 |
Metastasis to a single lymph node ² 2 cm |
|
N2 |
Metastasis to a single node > 2 cm |
|
Metastasis (M) |
|
|
Mx |
Metastasis cannot be assessed |
|
M0 |
No distant metastasis |
|
M1 |
Distant metastasis |
|
Adapted from Fleming ID et al.44 |
| |